Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathryn J Swoboda, M.D.
University of Utah/Primary Children's Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Sainte-Justine
Montreal, Quebec, Canada
- Johns Hopkins University
Baltimore, Maryland, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- Ohio State University
Columbus, Ohio, United States
- University of Utah/primary Children'S Medical Center
Salt Lake City, Utah, United States
- University of Wisconsin Children'S Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 30 Nov 2007
- Completion
- 30 Nov 2007
- Last update posted
- 19 Mar 2025
- Registered enrollment
- 94
- Registry id
- NCT00227266
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.